Active substances
Ibuprofen + Paracetamol
- US FDA 13
- Health Canada 4
- US price lines 1
- NHS prices 1
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| ADVIL DUAL ACTION WITH ACETAMINOPHEN | 250MG;125MG | tablet · oral | HALEON US HOLDINGS | Over-the-counter | 28 Feb 2020 |
| ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | tablet · oral | L PERRIGO CO | Over-the-counter | 28 Feb 2023 |
| COMBOGESIC | 325MG;97.5MG | tablet · oral | AFT PHARMS US | Prescription | 1 Mar 2023 |
| ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | tablet · oral | PHARMAZONE | Over-the-counter | 10 Jul 2023 |
| ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | tablet · oral | GRANULES | Over-the-counter | 13 Jul 2023 |
| ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | tablet · oral | BIONPHARMA | Over-the-counter | 1 Aug 2023 |
| COMBOGESIC IV | 1GM/100ML (10MG/ML);EQ 300MG BASE/100ML (EQ 3MG BASE/ML) | solution · intravenous | HIKMA PHARMS | Prescription | 17 Oct 2023 |
| ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | tablet · oral | AUROBINDO PHARMA LTD | Over-the-counter | 26 Mar 2024 |
| ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | tablet · oral | GLENMARK PHARMS LTD | Over-the-counter | 26 Apr 2024 |
| ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | tablet · oral | DR REDDYS | Over-the-counter | 23 Aug 2024 |
| ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | tablet · oral | LNK INTL INC | Over-the-counter | 11 Dec 2025 |
| ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | tablet · oral | TARO | Over-the-counter | 2 Jan 2026 |
| ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | tablet · oral | STRIDES PHARMA | Discontinued | 17 Jan 2025 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| ADVIL PLUS ACETAMINOPHEN | 02519267 | 125 MG; 250 MG | TABLET · ORAL | HALEON CANADA ULC |
| COMBOGESIC | 02488280 | 97.5 MG; 325 MG | TABLET · ORAL | AFT PHARMACEUTICALS (CAN) LIMITED |
| COMBOGESIC IV | 02544806 | 10 MG / ML; 3 MG / ML | SOLUTION · INTRAVENOUS | AFT PHARMACEUTICALS (CAN) LIMITED |
| TYLENOL DUAL ACTION ACETAMINOPHEN + IBUPROFEN | 02558572 | 125 MG; 250 MG | TABLET · ORAL | KENVUE CANADA INC. |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | GNP ACETAMINOPHEN-IBUPROFEN 250-125 MG TABLET | $0.10711 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Paracetamol 500mg / Ibuprofen 200mg tablets | £3.17 | 12 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.